Clinical Trial Update: European Trial of Immunosuppression in SPK Tx [Phase 3]

View source ↗

Summary

Phase 3 trial update of immunosuppression in simultaneous kidney-pancreas transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Snippet

Sponsor: EUROSPK Study Group | Conditions: Diabetes Mellitus, Type 1, Diabetic Nephropathy | Phase 3 | Status: COMPLETED